Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

Andrew H. Karaba, Jake D. Kim, Teresa Po‐Yu Chiang, Jennifer L. Alejo, Ioannis Sitaras, Aura T. Abedon, Yolanda Eby, Trevor S. Johnston, Maggie Li, Tihitina Y. Aytenfisu, Casey Hussey, Alexa Jefferis, Nicole Fortune, Rivka Abedon, Letitia Thomas, Feben Habtehyimer, Jessica E. Ruff, Daniel Warren, Robin K. Avery, William Clarke, Andrew Pekosz, Allan B. Massie, Aaron A.R. Tobian, Dorry L. Segev, William A. Werbel